Utilizing Botulinum Toxin for Managing First Bite Syndrome: An Injection Approach Based on Symptom Localization
-
By
-
Rosario Marchese-Ragona
-
Gianmarco Giunta
-
Daniela Adamo
-
Elisabetta Zanoletti
-
Daniele Manfredini
-
Domenico Antonio Restivo
-
July 1, 2026
Clinical Scorecard: Utilizing Botulinum Toxin for Managing First Bite Syndrome: An Injection Approach Based on Symptom Localization
At a Glance
| Category | Detail |
|---|
| Condition | First Bite Syndrome |
| Key Mechanisms | Autonomic imbalance leading to exaggerated myoepithelial contraction and acute parotid pain. |
| Target Population | Patients with postoperative First Bite Syndrome following head and neck surgery. |
| Care Setting | Otolaryngology–Head and Neck Surgery outpatient clinic. |
Key Highlights
- FBS is characterized by severe unilateral parotid pain triggered by the first bite of food.
- Botulinum toxin type A (BoNT-A) injections have shown efficacy in reducing pain intensity.
- The 'Follow-the-Pain' technique is proposed for targeted BoNT-A injection.
Guideline-Based Recommendations
Diagnosis
- Diagnosis is clinical, based on characteristic features of unilateral parotid pain.
Management
- BoNT-A injections are recommended for refractory symptoms.
Monitoring & Follow-up
- Monitor for pain intensity reduction and any adverse effects post-injection.
Risks
- Potential for inadequate response due to variability in injection techniques and dosing.
Patient & Prescribing Data
Patients diagnosed with FBS post head and neck surgery.
BoNT-A injections may provide significant clinical improvement in pain management.
Clinical Best Practices
- Utilize ultrasound guidance for BoNT-A injections to enhance targeting accuracy.
- Consider patient history and surgical background when diagnosing FBS.
Related Resources & Content
